{
    "nctId": "NCT04815642",
    "briefTitle": "Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery",
    "officialTitle": "Retrospective Study Evaluating Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Disease free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. women aged from 18 and up to 55 years old.\n2. Histologically diagnosed with breast carcinoma (ductal and others )\n3. All patients with conservative breast surgery.\n4. Including all patients with in all stages except those stage IV.\n5. All patients with clear free surgical margin.\n6. patients received hypofractionated radiotherapy with weekly concomitant boost\n\nExclusion Criteria:\n\n1. Evidence of distant metastatic deposites.\n2. patients with mastectomy\n3. patients with prior irradiation to thoracic region.\n4. pregnancy or lactation.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}